Evidence map›Paper›PMID 35883419›Full record

ArticleBiomolecules2022

The APE2 Exonuclease Is a Client of the Hsp70-Hsp90 Axis in Yeast and Mammalian Cells.

Siddhi Omkar, Tasaduq H Wani, Bo Zheng, Megan M Mitchem, Andrew W Truman

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Insights into Hsp90 mechanism andFrontiers in molecular biosciences · 2024
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Siddhi OmkarDepartment of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC 28223, USA.ORCID 0000-0002-3646-3950
Tasaduq H WaniDepartment of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC 28223, USA.ORCID 0000-0003-2234-9820
Bo ZhengDepartment of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
Megan M MitchemDepartment of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
Andrew W TrumanDepartment of Biological Sciences, The University of North Carolina at Charlotte, Charlotte, NC 28223, USA.ORCID 0000-0002-6409-3723
University of North Carolina at Charlotte · US

Funding

Understanding the reciprocal regulation between Hsp70 and the DNA damage response.R01GM139885 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI TRUMAN, ANDREW WILLIAM · 2021 to 2024
$1.4M
Understanding ER chaperone-mediated RNR regulationR15GM139059 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI TRUMAN, ANDREW WILLIAM · 2020 to 2020
$440k
NIGMS NIH HHS R01 GM139885NIGMS NIH HHS R15 GM139059NIH HHS R01GM139885NIH HHS R15GM139059
6 · The paper itself

Abstract

Molecular chaperones such as Hsp70 and Hsp90 help fold and activate proteins in important signal transduction pathways that include DNA damage response (DDR). Previous studies have suggested that the levels of the mammalian APE2 exonuclease, a protein critical for DNA repair, may be dependent on chaperone activity. In this study, we demonstrate that the budding yeast Apn2 exonuclease interacts with molecular chaperones Ssa1 and Hsp82 and the co-chaperone Ydj1. Although Apn2 does not display a binding preference for any specific cytosolic Hsp70 or Hsp90 paralog, Ssa1 is unable to support Apn2 stability when present as the sole Ssa in the cell. Demonstrating conservation of this mechanism, the exonuclease APE2 also binds to Hsp70 and Hsp90 in mammalian cells. Inhibition of chaperone function via specific small molecule inhibitors results in a rapid loss of APE2 in a range of cancer cell lines. Taken together, these data identify APE2 and Apn2 as clients of the chaperone system in yeast and mammalian cells and suggest that chaperone inhibition may form the basis of novel anticancer therapies that target APE2-mediated processes.

Indexed as

Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesAnimalsDNA-(Apurinic or Apyrimidinic Site) LyaseExodeoxyribonucleasesExonucleasesHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsMammalsMolecular ChaperonesProtein BindingAdenosine TriphosphatasesAPN2 protein, S cerevisiaeDNA-(Apurinic or Apyrimidinic Site) Lyaseexodeoxyribonuclease IExodeoxyribonucleasesExonucleasesHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSP82 protein, S cerevisiaeHSP90 Heat-Shock ProteinsMolecular ChaperonesSaccharomyces cerevisiae ProteinsSSA1 protein, S cerevisiaeYDJ1 protein, S cerevisiaeAPE2Apn2cancerchaperone inhibitionHsp70Hsp90

Identifiers

PMID35883419
PMCPMC9312491
OpenAlexW4283266611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.